FSDDF - FSD Pharma Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1830
-0.0130 (-6.63%)
At close: 3:40PM EDT
Stock chart is not supported by your current browser
Previous Close0.1960
Open0.1860
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1800 - 0.1860
52 Week Range0.0677 - 0.8750
Volume192,392
Avg. Volume431,365
Market Cap249.956M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0010
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • FSD Pharma Announces New Leadership Appointment and Board Change
    CNW Group5 days ago

    FSD Pharma Announces New Leadership Appointment and Board Change

    TORONTO , March 13, 2019 /CNW/ - FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), a licensed producer under the Cannabis Act, today announced that Sara May , Ph.D., has been appointed President of FV Pharma ("FV"), a wholly owned subsidiary of FSD Pharma, effective immediately. Dr. May replaces Thomas Fairfull , former President of FV Pharma, as Mr. Fairfull transitions out of the company.

  • CNW Group13 days ago

    High Tide Announces Both Cannabis Retail Store Lottery Counterparts in Ontario Proceeding to Eligibility Phase of AGCO Review

    High Tide Announces Both Cannabis Retail Store Lottery Counterparts in Ontario Proceeding to Eligibility Phase of AGCO Review

  • GlobeNewswire13 days ago

    FSD Pharma's Investments Provide Unique Diversification -- CFN Media

    SEATTLE, March 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FSD Pharma Inc. (CSE:HUGE) (FSDDF) (0K9.F). The company is best known for its 3.8 million square foot former Kraft Foods facility in Cobourg, Ontario, which could make it one of the largest licensed producers in the country, if approved by Health Canada. In addition to this massive footprint, the company has established many strategic alliances that have gone under-the-radar for many investors, but could generate significant long-term value.

  • CNW Group14 days ago

    High Tide Reports 2018 Financial Results

    High Tide Reports 2018 Financial Results

  • Market Exclusive18 days ago

    Cannabis Stock News Daily Roundup February 28

    Acreage Holdings (CSE: ACRG.U) (OTCQX: ACRGF) has opened three The Botanist-branded cannabis dispensaries in New York and Ohio. Following the development, Acreage now owns or has management services agreements in place for 23 dispensaries that are currently open in 11 states. High Hampton Holdings (CSE: HC) (FSE: 0HCN) has signed a binding letter of intent for a minority investment in […]The post Cannabis Stock News Daily Roundup February 28 appeared first on Market Exclusive.

  • FSD Pharma Enters into Five Year Supply and Loan Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal
    CNW Group18 days ago

    FSD Pharma Enters into Five Year Supply and Loan Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal

    TORONTO , Feb. 28, 2019 /CNW/ - FSD Pharma Inc. (CSE:HUGE) (FSDDF) (0K9.F) ("FSD" or the "Company"), a licensed producer under the Cannabis Act, announced today that it has entered into a supply and loan agreement (the "Agreement") with Canntab Therapeutics Ltd. ("Canntab") and World Class Extractions Inc. ("World Class") (collectively, the "Purchasers") to purchase hemp flower from Thomas Elcome (the "Supplier"). Pursuant to the Agreement, the Supplier grants the Purchasers the right and option to purchase up to CAD$ 5.0 million of the Supplier's hemp crop for a period of 5 years commencing in 2019 at a purchase price of CAD$ 100.0 per kg per 1% of CBD extracted from the flower.

  • GlobeNewswire19 days ago

    Cannabis and Cleantech; The Green, Clean Machine of The Future

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing interest in renewable energy and sustainable practices within the cannabis industry, sparked largely by high demand, high energy usage and a need for companies to lower costs and improve efficiency. “Legal cannabis cultivation in the U.S. consumes an estimated 1.1 terawatt-hours of electricity a year,” according to the 2018 Cannabis Energy Report, published by Scale Microgrid Solutions, along with New Frontier Data and the Resource Innovation Institute. Aurora Cannabis Inc. (TSX:ACB.TO) (NYSE:ACB) has been aware of this need for energy efficiency since 2017, having partnered with Flora Fotonica through the company’s subsidiary MedReleaf.

  • CNW Group19 days ago

    High Tide Announces the Opening of its Tenth Canna Cabana Store

    CALGARY , Feb. 27, 2019 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (CSE:HITI) (2LY.F), an Alberta -based downstream cannabis corporation focused on the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today announced that it has been licensed to open its tenth Canna Cabana retail store, which is located at 11032 Elbow Drive SW in Calgary, Alberta (the "Elbow Drive Store"). Having met all municipal business requirements, the Elbow Drive Store is approved to sell smoking accessories and cannabis lifestyle products while the temporary suspension of incremental cannabis retail licensing (the "Moratorium") by Alberta Gaming, Liquor and Cannabis (the "AGLC") remains in effect.

  • GlobeNewswire20 days ago

    FSD Pharma's Investments in Cutting-Edge Tech Could Pay Big Dividends -- CFN Media

    SEATTLE, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FSD Pharma Inc. (CSE:HUGE) (FSDDF) (0K9.F). The company has become well-known for its massive cannabis cultivation facility that’s being built in a former Kraft plant in Cobourg, Ontario, but investors should also take note of its investment in cutting-edge research and development, including delivery systems and cultivation techniques. Many cannabis companies have predictable business models—they grow and sell cannabis flower or perhaps extract them into edibles or vape pens.

  • CNW Group25 days ago

    High Tide Announces the Opening of its Ninth Canna Cabana Store

    CALGARY , Feb. 21, 2019 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (CSE:HITI) (2LY.F), an Alberta -based downstream cannabis corporation focused on the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today announced that it has been licensed to open its ninth Canna Cabana retail store, which is located at #105, 330 10th Street NW in Calgary, Alberta (the "Kensington Store"). The Kensington Store has been converted from a Smoker's Corner location and is now the first franchised Canna Cabana outlet in the High Tide network.

  • FSD Pharma Receives Standard Processing License
    CNW Group28 days ago

    FSD Pharma Receives Standard Processing License

    TORONTO , Feb. 19, 2019 /CNW/ - FSD Pharma Inc. ("FSD Pharma" or the "Company") (CSE:HUGE) (FSDDF) (0K9.F) announced today that its wholly-owned subsidiary, FV Pharma Inc. ("FV Pharma"), a licensed cannabis producer under the Cannabis Act, has received its Standard Processing License (the "Processing License"). According to Health Canada's new Cannabis Act regulations, the Processing License is required for any facility that is processing more than the equivalent of 600 kg of dried flowers per year. Dr. Raza Bokhari , Executive Co-Chairman and Interim CEO, stated, "This is a milestone for our Company and is welcome news for our Cobourg facility. Receiving the Processing License allows the Company to begin packaging cannabis for inspection by Health Canada.

  • Business Wirelast month

    FSD Pharma Provides Update on Operations, Strategy and Leadership

    FSD Pharma Inc. (CSE:HUGE) (FSDDF) (0K9.F) (“FSD”), a licensed producer under the Cannabis Act, today provided a corporate update on operations, strategy and leadership changes. On February 6, 2019, the Company announced it had implemented changes in leadership and business practices to optimize operations. Accordingly, the Company announced that Dr. Raza Bokhari, Executive Co-Chairman, has been appointed interim Chief Executive Officer of FSD Pharma.

  • FSD Pharma Enters into Supply Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal
    CNW Grouplast month

    FSD Pharma Enters into Supply Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal

    TORONTO , Feb. 12, 2019 /CNW/ - FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD"), a licensed producer under the Cannabis Act, announced today that it has entered into a supply agreement (the "Agreement") with Canntab Therapeutics Ltd. ("Canntab") and World Class Extractions Inc. ("World Class") (the "Purchasers") to purchase hemp flower from Thomas Elcome (the "Supplier"). Pursuant to the agreement, the Purchasers have agreed to buy approximately 1,000 kg of the Supplier's 2018 hemp crop at a purchase price of $100.00 per kg per 1% of CBD extracted from the flower.

  • FSD Pharma responds to and corrects misleading Auxly claims
    CNW Grouplast month

    FSD Pharma responds to and corrects misleading Auxly claims

    FSD Pharma strongly denies that it caused any breaches of the Streaming Agreement relating to its management and staffing obligations or otherwise, and rejects the claim that there are material issues with the infrastructure of its cultivation facility in Cobourg, Ontario . "FSD's Board and management team are focused on taking action to deliver on a strategy that promotes growth and creates shareholder value. As disclosed on Wednesday, February 6 , FSD terminated the Definitive Agreement with Auxly.

  • Business Wirelast month

    FSD Pharma Responds to and Corrects Misleading Auxly Claims

    FSD Pharma Inc.(HUGE.CN) (FSDDF) (0K9.F) a licensed producer under the Cannabis Act, responded today to a press release by its former partner, Auxly Cannabis Group Inc. (“Auxly”) to correct misleading claims. FSD Pharma strongly denies that it caused any breaches of the Streaming Agreement relating to its management and staffing obligations or otherwise, and rejects the claim that there are material issues with the infrastructure of its cultivation facility in Cobourg, Ontario. “FSD’s Board and management team are focused on taking action to deliver on a strategy that promotes growth and creates shareholder value.

  • Business Wirelast month

    FSD Pharma Signs Collaboration and Profit-Sharing Agreement with Pharmastrip for Production and Delivery of Organic Medical Cannabis Infused in Oral Thin Film Strips

    FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) (“FSD” or the “Company), a licensed producer under the Cannabis Act, announced today that it has completed a strategic investment of $1.5 million in Pharmastrip Corp. and signed a definitive collaboration and profit sharing agreement with the company, effective January 23, 2019. Under the terms of the agreement, FSD will install Pharmastrip proprietary equipment at its facility in Cobourg, Ontario.

  • FSD Pharma Announces Strategic Business Developments
    CNW Grouplast month

    FSD Pharma Announces Strategic Business Developments

    TORONTO , Feb. 6, 2019 /CNW/ - FSD Pharma Inc. (HUGE.CN) (FSDDF) (0K9.F) ("FSD" or the "Company"), announced that its Board of Directors has concluded a strategic assessment of the Company and has implemented changes in leadership and business practices to optimize operations. Accordingly, the Company announced today that Dr. Raza Bokhari , Executive Co-Chairman, has been appointed interim Chief Executive Officer of FSD Pharma, effective immediately.

  • Newsfilelast month

    InvestmentPitch Media Video Discusses Licensed Cannabis Producer FSD Pharma's LOI with Solarvest BioEnergy to Develop and Test Production of Pharma-Grade Cannabinoids from Algae - Video Available on Investmentpitch.com

    Vancouver, British Columbia--(Newsfile Corp. - February 6, 2019) -  FSD Pharma Inc. (CSE: HUGE) (FSE: 0K9) (OTCQB: FSDDF), a licensed cannabis producer, has signed a non-binding letter of intent with Solarvest BioEnergy Inc. to develop and test the production of pharma-grade cannabinoids from algae.Solarvest BioEnergy Inc. (TSXV:SVS), an algae technology company, has developed a platform capable of producing health products such as "Organic Omega 3 DHA" fruit gummies and food boosting powders, and has ...